News|Videos|May 18, 2026

How Online-Informed Patients Are Changing Dermatology Visits

Author(s)Raj Chovatiya, MD, PhD, Kathryn Celeste Durham, MD, David Cotter, MD, PhD

Fact checked by: Tim Smith

As dermatology patients enter clinical visits with information from social media, online forums, and AI inquiries, clinicians are juggling new concerns.

In recent years, the rise of the “online-informed” patient has transformed visits to dermatology practices, with clinicians increasingly encountering patients who greet them armed with TikTok skincare advice, Reddit-informed treatment data, AI-generated differential diagnoses, and screenshots from ChatGPT inquiries. In this feature, interviews between 4 leaders in dermatology and HCPLive highlight this trend as being simultaneously empowering to patients and potentially hazardous.

Related to this article

September 30th, 2026

EADV 2026: Zasocitinib Tops Deucravacitinib for PASI 100 in Plaque Psoriasis

Zasocitinib achieved PASI 100 in 36.5% of patients vs 13.9% with deucravacitinib at week 16 in the phase 3 LATITUDE Atlas psoriasis trial.

September 28th, 2026

Skin of Color Savvy: Reimbursement, Coverage, and Care Gaps for Patients With Skin of Color

Murad Alam, MD, and Elizabeth Kiracofe, MD, discuss how reimbursement, coverage, and advocacy shape dermatology access for patients with skin of color.

September 24th, 2026

The Medical Sisterhood: Is Becoming a Doctor Still Worth It?

Andrea Murina, MD, weighs whether she would recommend medicine to her own children amid AI, physician burnout, and evolving residency training standards.

October 2nd, 2026

ICONIC-TOTAL: Icotrokinra Sustains High-Impact Site Clearance at 2 Years

Oral icotrokinra sustained clearance at scalp, genital, hand/foot, and nail sites through Week 112 in ICONIC-TOTAL, with no rise in adverse event rates.